Chris Milross

Chris O’Brien Lifehouse

Papers

2

Total Citations

30

H-Index

2

About

Chris Milross is a leading researcher in head and neck oncology, with a primary focus on swallowing and communication outcomes following transoral robotic surgery (TORS) for oropharyngeal cancer. His work addresses critical gaps in understanding functional recovery after minimally invasive surgical interventions. In his highly cited 2021 study (25 citations), Milross systematically evaluated swallowing and communication outcomes after primary TORS, highlighting the heterogeneity in existing research and the need for standardized instrumental swallow examinations to draw clearer conclusions. His 2022 cohort study (5 citations) further advanced the field by investigating the feasibility of avoiding primary site adjuvant radiotherapy after TORS, analyzing disease control and swallowing function to potentially reduce treatment-related morbidity. Milross’s contributions are pivotal in refining post-operative protocols, aiming to preserve quality of life while maintaining oncologic efficacy. His research is widely referenced by clinicians and researchers seeking evidence-based strategies to optimize functional outcomes in head and neck cancer survivors, establishing him as a key voice in the evolution of organ-preserving surgical approaches.

Research Focus

Key Achievements

2
H-Index
2
Papers
30
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Swallowing and communication outcomes following primary transoral robotic surgery
25 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Chris O’Brien Lifehouse

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago